Literature DB >> 11980741

Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS.

T Al-Shawaf1, A Zosmer, A Tozer, C Gillott, A M Lower, J G Grudzinskas.   

Abstract

BACKGROUND: Withholding gonadotrophins (coasting) can reduce the risk of severe ovarian hyperstimulation syndrome (OHSS) in patients having assisted reproduction therapy. This requires daily serum estradiol (E(2)) measurements, which occasionally have been seen to decline suddenly and sharply.
METHODS: To increase the sensitivity of the coasting programme we measured serum FSH in parallel with E(2) in patients at risk of developing OHSS.
RESULTS: Out of a total of 1240 cycles, 106 were coasted and in 89 both serum E(2) and FSH were measured at least twice during the coasting period. One case of late severe OHSS was encountered in the study group. The serum FSH declined by a rate of 24.3 +/- 4.5% per day. Serum E(2) level reached a 'safe level' of <10,000 pmol/l when the serum FSH declined to 5 IU/l or less.
CONCLUSION: The results from this study show that measuring serum E(2) and FSH can assist in predicting the point at which serum E(2) has declined to a level safe enough to administer the trigger HCG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980741     DOI: 10.1093/humrep/17.5.1217

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

Review 1.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.

Authors:  Srisailesh Vitthala; Jerome Bouaziz; Amanda Tozer; Ariel Zosmer; Talha Al-Shawaf
Journal:  Int J Endocrinol       Date:  2012-02-12       Impact factor: 3.257

3.  Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?

Authors:  Ömer Hamid Yumuşak; Serkan Kahyaoğlu; Ayşe Seval Özgü Erdinç; Saynur Yılmaz; Yaprak Engin Üstün; Nafiye Yılmaz
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.